Actionnariat et activité des initiés pour Codexis, Inc. (CDXS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.34 |
| Capitalisation | $144M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $19.2M | $31.2M | $53.0M | $90.5M | $149.1M | $116.8M | $114.0M | $65.1M | $19.3M | $50.8M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | $1.0M | 0 | 0 | 0 | $54.2M | $27.4M |
| Créances | $5.9M | $11.8M | $13.5M | $20.2M | $29.3M | $37.7M | $40.9M | $19.9M | $18.9M | $10.7M |
| Stocks | $825000 | $1.0M | $589000 | $371000 | $964000 | $1.2M | $2.0M | $2.7M | $1.8M | $1.8M |
| Actifs Courants | $27.2M | $45.0M | $68.2M | $114.2M | $184.4M | $161.9M | $162.9M | $93.5M | $98.8M | $96.8M |
| Immobilisations Corporelles | $2.2M | $2.8M | $4.8M | $30.4M | $31.2M | $65.5M | $61.9M | $28.6M | $42.9M | $43.5M |
| Goodwill | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $2.5M | $2.5M | $2.5M |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $35.6M | $53.6M | $79.3M | $149.1M | $221.6M | $246.4M | $250.4M | $136.6M | $149.0M | $147.8M |
| Dettes Fournisseurs | $4.2M | $3.5M | $3.0M | $2.6M | $3.0M | $3.0M | $3.2M | $5.9M | $2.8M | $1.6M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $12.4M | $25.0M | $17.1M | $15.4M | $25.0M | $33.4M | $49.1M | $35.8M | $23.6M | $25.3M |
| Dette à Long Terme | $885000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $28.9M | $40.1M |
| Passifs Totaux | $16.5M | $29.1M | $22.0M | $43.6M | $51.5M | $82.0M | $105.6M | $49.9M | $82.1M | $97.3M |
| Réserves | -$292.1M | -$315.1M | -$330.5M | -$342.4M | -$366.4M | -$387.7M | -$421.3M | -$497.5M | -$562.8M | -$606.8M |
| Capitaux Propres | $19.1M | $24.5M | $56.3M | $105.5M | $170.1M | $164.4M | $144.8M | $86.6M | $66.9M | $50.5M |
| Dette Totale | $425000 | $302000 | $303000 | $26.1M | $25.0M | $47.7M | $43.6M | $16.0M | $59.9M | $73.2M |
| Dette Nette | -$18.8M | -$30.9M | -$52.7M | -$64.4M | -$125.2M | -$69.1M | -$70.3M | -$49.1M | -$13.6M | -$5.0M |
| Fonds de Roulement | $14.9M | $20.1M | $51.1M | $98.8M | $159.4M | $128.5M | $113.8M | $57.6M | $75.1M | $71.5M |
Santé financière
| Dette / Capitaux propres | 2.20 |
| Ratio de liquidité | 3.06 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -4.67 |
Rentabilité
| Rentabilité des capitaux propres | -74.36% |
| Rentabilité du capital investi | -22.69% |
| Rentabilité des actifs | -25.59% |
| Marge brute | 83.71% |
| Marge opérationnelle | -31.23% |
| Marge nette | -39.55% |
Entreprises liées: ARMP · CCCC · GNFT · IMDX · IPHA · IVVD · OABI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CDXS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions